BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21983449)

  • 21. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
    Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
    Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1.
    Giacomelli R; Cipriani P; Danese C; Pizzuto F; Lattanzio R; Parzanese I; Passacantando A; Perego MA; Tonietti G
    J Rheumatol; 1996 Feb; 23(2):291-6. PubMed ID: 8882034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
    Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
    Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.
    Manetti M; Pratesi S; Romano E; Bellando-Randone S; Rosa I; Guiducci S; Fioretto BS; Ibba-Manneschi L; Maggi E; Matucci-Cerinic M
    PLoS One; 2017; 12(8):e0183102. PubMed ID: 28797111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma.
    Głodkowska-Mrówka E; Górska E; Ciurzyński M; Stelmaszczyk-Emmel A; Bienias P; Irzyk K; Siwicka M; Lipińska A; Ciepiela O; Pruszczyk P; Demkow U
    Respir Physiol Neurobiol; 2015 Apr; 209():69-75. PubMed ID: 25447676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
    Brown M; Postlethwaite AE; Myers LK; Hasty KA
    Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.
    Andrigueti FV; Arismendi MI; Ebbing PC; Kayser C
    Microvasc Res; 2015 Mar; 98():82-7. PubMed ID: 25596148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.
    Kylhammar D; Hesselstrand R; Nielsen S; Scheele C; Rådegran G
    Scand J Rheumatol; 2018 Jul; 47(4):319-324. PubMed ID: 29528272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
    Griga T; Hebler U; Voigt E; Tromm A; May B
    Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis and vasculogenesis in systemic sclerosis.
    Distler JH; Gay S; Distler O
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii26-7. PubMed ID: 16987827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
    Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis.
    Sato S; Hanakawa H; Hasegawa M; Nagaoka T; Hamaguchi Y; Nishijima C; Komatsu K; Hirata A; Takehara K
    J Rheumatol; 2000 Dec; 27(12):2838-42. PubMed ID: 11128673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma).
    Rudnicka L; Majewski S; Blaszczyk M; Skiendzielewska A; Makiela B; Skopinska M; Jablonska S
    Arthritis Rheum; 1992 Jul; 35(7):771-5. PubMed ID: 1622415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A vascular endothelial growth factor deficiency characterises scleroderma lung disease.
    De Santis M; Bosello SL; Capoluongo E; Inzitari R; Peluso G; Lulli P; Zizzo G; Bocci M; Tolusso B; Zuppi C; Castagnola M; Ferraccioli G
    Ann Rheum Dis; 2012 Sep; 71(9):1461-5. PubMed ID: 22402140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome.
    Kosaka K; Fujiwara H; Yoshioka S; Fujii S
    Hum Reprod; 2007 Jun; 22(6):1647-51. PubMed ID: 17356124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
    Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
    Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor production in polymyalgia rheumatica.
    Meliconi R; Pulsatelli L; Dolzani P; Boiardi L; Macchioni P; Salvarani C; Silvestri T; Frizziero L; Facchini A
    Arthritis Rheum; 2000 Nov; 43(11):2472-80. PubMed ID: 11083270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.